ArticleFrontiers in oncology2021

Tyrosine Kinase Inhibitor Cabozantinib Inhibits Murine Renal Cancer by Activating Innate and Adaptive Immunity.

Hongyan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.